| abstract |
The present invention relates to a method for preventing and/or treating tinnitus caused by cochlear excitotoxicity. In these embodiments, the pharmaceutical composition comprising the NMDA receptor antagonist is applied to the human body using appropriate equipment and/or formulations for topical administration to the inner ear. The tinnitus to be prevented and/or treated is caused by hearing impairment, presbycusis, myocardial ischemia, hypoxia, treatment with one or more specific ototoxic drugs, sudden deafness, or other cochlear Induced by excitotoxic mutagenesis. |